Skip to main content
. 2022 Jan 31;23(3):1664. doi: 10.3390/ijms23031664

Table 1.

Five highest over-represented pathways 1 identified for validated target genes of the RRMS-specific miRNAs.

Pathway Adjusted p Value miRNA Target Transcripts
Vesicle-mediated transport 2.41 × 108 miR-16-5p RAB9B, CAPZA2, DCTN5, GALNT1, RAB30, PPP6R3, RAB3IP, SBF1, TBC1D14, KIF2A, RACGAP1, KIF3B, KIF1B, TFRC, COL4A1
miR-6840-3p TRAPPC2, ACTR1A, FZD4, GNS, TBC1D24, GJC1, APOL1
miR-6811-3p RAB13, RAB30, PAFAH1B2, DENND6B
miR-5192 CBL, CSNK1D, TBC1D13, SYT2, CALR
miR-4476 RAB5B, ACTR2, PACSIN1
miR-135b-5p RAB3GAP2
Membrane trafficking 2.96 × 108 miR-6840-3p TRAPPC2, ACTR1A, FZD4, GNS, TBC1D24, GJC1
miR-6811-3p RAB13, RAB30, PAFAH1B2, DENND6B
miR-5192 CBL, CSNK1D, TBC1D13, SYT2
miR-4476 RAB5B, ACTR2, PACSIN1
miR-135b-5p RAB3GAP2
Post-translational protein modification 1.87 × 107 miR-16-5p RAB9B, CAPZA2, DCTN5, GALNT1, RAB30, PPP6R3, BIRC5, MAP3K7, SOCS2, NUP155, NCOR2, BRCA1, CUL3, FBXL20, B3GNT2, RAB23, GALNT7, ASXL1
miR-6840-3p TRAPPC2, ACTR1A, APOL1, MLEC, RCE1, SUMF2, GGCX, DCAF10, FOXK1, CPM
miR-4476 RAB5B, PSMD11, PHC2, TFAP2A, USP12, IGFBP4
miR-1909-3p CANX, TFAP2B, SENP5, DPH2, WAC
miR-5192 CSNK1D, CALR, ST6GAL2, RECK
miR-6811-3p RAB13, RAB30, KLHL21, PEX2
miR-135b-5p THBS2
Signalling by interleukins 1.87 × 107 miR-16-5p BIRC5, MAP3K7, SOCS2, VEGFA, RPS6KA3, UBE2V1, BCL2, IRAK3, PIM1, HNRNPDL
miR-5192 CBL, SOD2, POU2F1, UBE2V1, STX3
miR-4476 PSMD11, SOD2, CFL1, IFNLR1
miR-1909-3p CANX, IRAK4, MCL1
miR-6840-3p CRK, IL6R, STAT2
miR-135b-5p STAT6
miR-6811-3p CCR2
Cytokine signalling in immune system 1.23 × 106 miR-16-5p BIRC5, MAP3K7, SOCS2, VEGFA, RPS6KA3, UBE2V1, BCL2, IRAK3, PIM1, HNRNPDL, NUP155, KRAS, CD44
miR-5192 CBL, SOD2, POU2F1, UBE2V1, STX3, EDAR
miR-4476 PSMD11, SOD2, CFL1, IFNLR1
miR-1909-3p CANX, IRAK4, MCL1
miR-6840-3p CRK, IL6R, STAT2
miR-6811-3p CCR2, PDE12
miR-135b-5p STAT6

1 “Top five” over-represented pathways in the Reactome Pathway Database were defined as those with the lowest adjusted p values from the list of pathways with a BH-corrected p value ≤ 0.01 and with ≥3 RRMS-specific miRNAs having predictive mRNA targets inherent to the biological pathway.